Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

Investor Relations

Copyright West LLC. Minimum 15 minutes delayed.

News Releases
November 27, 2018
electroCore Expands Manufacturing Capabilities for gammaCore™
BASKING RIDGE, N.J. , Nov. 27, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc.  (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced expansion into a new design and development facility to support increasing patient demand of its gammaCore™ non-invasive vagus
November 20, 2018
electroCore, Inc. to Present at the Evercore ISI HealthCONx Conference
BASKING RIDGE, N.J. , Nov. 20, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the company will be participating in the upcoming Evercore ISI HealthCONx Conference in Boston, MA.

Investor Contact

Investor Relations

Lynn Pieper Lewis
investors@electrocore.com